Abstract
Features of tumor and host zinc metabolism are described. Emphasis is placed on tumor-host interactions. Using the model of the Ehrlich ascites tumor in mice, one clear site of modulation of cellular zinc by the amount of nutrient zinc available in the host is a zinc-binding protein with the properties of metallothionein. The selective depletion of zinc from this protein is correlated with the loss of cell proliferation by tumors injected into zinc-deficient animals. The properties of isolated metallothionein are consistent with a role for it as a reactive pool of intracellular zinc which can be donated to apozinc proteins and other structures. The presence of the Ehrlich tumor in mice also perturbs their distribution of zinc: zinc leaves the plasma and is accumulated by liver in the form of newly synthesized zinc metallothionein. During host zinc deficiency, this redistribution is not observed. This may be caused not only by a lack of mobile plasma zinc, but also by an inhibition of the initiation of this host response at the site of the tumor in the peritoneum.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
G.N. Schrauzer, Ed.,Inorganic and Nutritional Aspects of Cancer, Adv. Expl. Med. Biol. 91, Plenum, NY, 1978.
W. R. Todd, C. A. Elvehjem, and E. B. Hart,Amer. J. Physiol. 107, 146.
R. W. Leucke, C. E. Simond, and P. J. Fraker,J. Nutr. 108, 881 (1978).
L. S. Hurley,The Johns Hopkins Medical Journal 148, 1 (1981).
H. G. Petering, H. H. Buskirk, and J. A. Crim,CancerRes. 27, 1115 (1967).
W. DeWys, W. J. Pories, M. C. Richter, and W. H. Strain,Proc. Soc. Expl. Biol. Med. 135, 17 (1970).
J.T. McQuitty, Jr., W. D. DeWys, L. Monaco, W. H. Strain, C. G. Rob, J. Apgar, and W. J. Pories,Cancer Res. 30, 1387 (1970).
D. Minkel, P. T. Dolhun, B. L. Calhoun, L. A. Saryan, and D. H. Petering,Cancer Res. 39, 2451 (1979).
L.A. Saryan, D. T. Minkel, P. T. Dolhun, B. L. Calhoun, S. Wielgus, M. Schaller, and D. H. Petering,Cancer Res. 39, 2457 (1979).
D. H. Petering and L. A. Saryan,Biol. Trace Element Res. 1, 87 (1979).
J. Koch, S. Wielgus, B. Shankara, L. A. Saryan, C. F. Shaw, and D. H. Petering,Biochem. J. 189, 95 (1980).
D.H. Petering, A. Kraker, G. Krakower, G. Bachowski, and C. F. Shaw,Fed. Proc. 41 (3); Abs. 2168 (1982).
J. P. Slater, A. S. Mildvan, and L. A. Loeb,Biochem. Biophys. Res. Commun. 44, 37 (1971).
M. C. Scrutton, W. C. Wu, and D. A. Goldthwait,Proc. Natl. Acad. Sci. USA 68, 2497 (1971).
K. H. Falchuk, C. Hardy, L. Ulpino, and B. L. Vallee,Proc. Natl. Acad. Sci. USA 75, 4175 (1978).
E. P. Anderson, in P. D. Boyer (ed.),The Enzymes, 3rd Ed., Vol IX, Academic Press, NY, 1973, pp. 69–93.
A. Askari, C. L. Long, and W. S. Blakemore,J. Parenteral Enteral Nutr. 4, 561 (1980).
M. Powanda, in K. D. Rainsford, K. Brune, and N. W. Whitehouse, eds.,Trace Elements in the Pathogenesis and Treatment of lnflammation, Birkhauser Verlag, Boston, 1981, pp. 121–135.
P.Z. Sobocinski, W. J. Canterbury, Jr., C. A. Mapes, and R. E. Dinterman,Amer. J. Phsyiol. 234, E399 (1978).
R. F. Kampschmidt,J. Reticuloendothel. Soc. 23, 287 (1978).
A. L. deWeek, F. Kristensen, and M. Landy,Biochemical Characterization of Lymphokines, Academic Press, New York, 1980, p. 417.
D.T. Minkel, K. Poulsen, S. Wielgus, C. F. Shaw III, and D. H. Petering,Biochem. J. 191, 475 (1980).
T. Y. Li, A. J. Kraker, C. F. Shaw III, and D. H. Petering,Proc. Natl. Acad. Sci.USA 77, 6334 (1980).
F. O. Brady,Trends Biol. Sci. 7, 143 (1982).
M. Webb and K. Cain,Biochem. Pharmacol. 31, 137 (1982).
A. J. Kraker, G. Krakower, C. F. Shaw III, and D. H. Petering, unpublished information.
R. J. Cousins,Am. J. Clin. Nutr. 32, 339 (1979).
A. O. Udom and F. O. Brady,Biochem. J. 187, 329 (1980).
J. D. Otvos and I. M. Armitage,Proc. Natl. Acad. Sci. USA 77, 7094 (1980).
G. Bachowski, C. F. Shaw, and D. H. Petering, unpublished information.
D. H. Petering,Biochem. Pharmacol. 23, 567 (1974).
S. Lindskog and P. O. Nyman,Biochim. Biophys. Acta 85, 462 (1964).
A. J. Zelazowski and J. K. Piotroski,Experentia 33, 1624 (1977).
A. J. Kraker and D. H. Petering, unpublished information.
S. R. Kern, H. A. Smith, D. Fontaine, and S. E. Bryan,Toxicol. Appl. Pharmacol. 59, 346 (1981).
H. Ohtake, K. Hasegawa, and M. Koga,Biochem. J. 174, 999 (1978).
B. Shankara, G. Krakower, G. Bachowski, C. F. Shaw III, and D. H. Petering, 13th International Cancer Congress, Seattle, Washington, USA, 1982, Abst. 2277.
B. Ujjani, G. Krakower, C. J. Shaw III, and D. H. Petering, unpublished information.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kraker, A.J., Petering, D.H. Tumor-host zinc metabolism the central role of metallothionein. Biol Trace Elem Res 5, 363–374 (1983). https://doi.org/10.1007/BF02987220
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02987220